| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/17/2002 | EP1196773A1 E4orf4 and pp2a polypeptides, modulators, and mimetics for selectively inducing cell death |
| 04/17/2002 | EP1196638A1 USE OF THE i KRIT1 /i GENE IN ANGIOGENESIS |
| 04/17/2002 | EP1196635A2 Cell death related drug targets in yeast and fungi |
| 04/17/2002 | EP1196616A2 Replication-competent anti-cancer vectors |
| 04/17/2002 | EP1196598A1 Dsp-3 dual-specificity phosphatase |
| 04/17/2002 | EP1196595A2 Methods of inducing cell death |
| 04/17/2002 | EP1196579A2 Tryptase inhibitor |
| 04/17/2002 | EP1196577A2 Cell cycle and proliferation proteins |
| 04/17/2002 | EP1196574A2 Human proteins involved in detoxification |
| 04/17/2002 | EP1196569A2 Electron transfer proteins |
| 04/17/2002 | EP1196568A1 Human lim domain proteins |
| 04/17/2002 | EP1196567A2 Human immune response molecules |
| 04/17/2002 | EP1196565A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/17/2002 | EP1196560A1 Neurotrophic factor receptor gfr-alpha-4 |
| 04/17/2002 | EP1196443A2 Erythropoietin conjugates with polyethylenglycol |
| 04/17/2002 | EP1196441A1 Keratinocyte growth factor-2 |
| 04/17/2002 | EP1196440A2 Therapeutic peptides derived from subsequences of bpi |
| 04/17/2002 | EP1196435A1 Recombinant adenovirus |
| 04/17/2002 | EP1196433A2 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN ALPHA v BETA 6 |
| 04/17/2002 | EP1196428A1 11$g(b)-ARYL-17,17-SPIROTHIOLANE-SUBSTITUTED STEROIDS |
| 04/17/2002 | EP1196427A2 Novel c-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 04/17/2002 | EP1196419A1 Potassium channel blocking agents |
| 04/17/2002 | EP1196407A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors |
| 04/17/2002 | EP1196406A1 Amino ceramide-like compounds and therapeutic methods of use |
| 04/17/2002 | EP1196394A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 04/17/2002 | EP1196390A2 Pyrazole compositions useful as inhibitors of erk |
| 04/17/2002 | EP1196193A2 Interleukin-1 muteins useful as vaccine adjuvants |
| 04/17/2002 | EP1196191A1 Death domain containing receptor 5 |
| 04/17/2002 | EP1196186A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 04/17/2002 | EP1196169A1 Compounds having cytokine inhibitory activity |
| 04/17/2002 | EP1196162A1 Procyanidin oligomers for inhibiting matrix metalloproteinases and medicine having effective composition of same |
| 04/17/2002 | EP1196144A2 A liposome composition having resistance to freeze/thaw damage |
| 04/17/2002 | EP1196047A1 Prophylactic dietary supplement based on milk |
| 04/17/2002 | EP1196043A1 An effervescent green tea extract formulation |
| 04/17/2002 | EP1019037B9 Medicament containing delta-aminolevulinic acid |
| 04/17/2002 | EP0937038B1 Vitamin d analogues |
| 04/17/2002 | EP0902783B1 Hydrolysis-promoting taxane hydrophobic derivatives |
| 04/17/2002 | EP0901378B1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid |
| 04/17/2002 | EP0662827B1 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids |
| 04/17/2002 | CN1345374A HER-2/neu fusion proteins |
| 04/17/2002 | CN1345373A Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
| 04/17/2002 | CN1345334A Antibodies specific to KDR and uses thereof |
| 04/17/2002 | CN1345331A Method and composition for angiogenesis inhibition |
| 04/17/2002 | CN1345329A Tumor mecrosis factor receptors 6 alpha and beta |
| 04/17/2002 | CN1345321A Optically pure camptothecin analogues |
| 04/17/2002 | CN1345315A Hydroxymatatairesinol in cancer prevention |
| 04/17/2002 | CN1345312A Dibenzoazulene derivatives for treating thrombosis, osteoporosis arteriosclerosis |
| 04/17/2002 | CN1345307A N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
| 04/17/2002 | CN1345249A Kit for radiolabeling proteins with yttrium-90 |
| 04/17/2002 | CN1345247A Expression vectors and cell lines expressing vascular endothelial growth factor D, and method of treating melanomas |
| 04/17/2002 | CN1345246A Compositions and method for prevention or treatment of cancer and bone loss associated with cancer |
| 04/17/2002 | CN1345242A Method for treatment of leukaemia |
| 04/17/2002 | CN1345240A Improved cancer treatment with temozolomide |
| 04/17/2002 | CN1344747A Antitumor carboxyalkyl achyranthis polysaccharide |
| 04/17/2002 | CN1344746A Prepn and application of individual antitumor specific antibody |
| 04/17/2002 | CN1344722A Amino polyoligoglucosan with 1-6 connection and glucoside and their synthesis and application |
| 04/17/2002 | CN1344566A Tumor vaccine constituting method by combining dendritic cell multiplication and chemotaxis factor and suicide gene |
| 04/17/2002 | CN1344556A Bladder cancer treating Chinese medicine |
| 04/17/2002 | CN1344553A Cancer preventing combined health yew decoction and its making process |
| 04/17/2002 | CN1344548A Blood clot dispersing and tumor eliminating capsule |
| 04/17/2002 | CN1082821C Antibody cojugates |
| 04/17/2002 | CN1082813C Stabized solutions of platinum (II) antitumor agents |
| 04/16/2002 | US6372926 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin D, methods for their production and pharmaceutical compositions thereof |
| 04/16/2002 | US6372777 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/16/2002 | US6372776 Crystalline(−)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleate |
| 04/16/2002 | US6372768 2-aminopyridines containing fused ring substituents |
| 04/16/2002 | US6372767 Benzanilides as potassium channel openers |
| 04/16/2002 | US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 04/16/2002 | US6372754 Drugs for treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpic neuralgia. |
| 04/16/2002 | US6372753 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
| 04/16/2002 | US6372751 Drugs with benzene and pyrimidine rings |
| 04/16/2002 | US6372747 Farnesyl protein transferase inhibitors |
| 04/16/2002 | US6372741 Use of CSAID™ compounds as inhibitors of angiogenesis |
| 04/16/2002 | US6372739 Coumarone derivatives for drugs |
| 04/16/2002 | US6372738 Cytotoxic agents comprising taxanes and their therapeutic use |
| 04/16/2002 | US6372731 Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 04/16/2002 | US6372726 Methods of cancer treatment using NAALADase inhibitors |
| 04/16/2002 | US6372719 ανβ3 integrin antagonists in combination with chemotherapeutic agents |
| 04/16/2002 | US6372490 Nucleic acid encoding the MDM interacting protein |
| 04/16/2002 | US6372473 Tissue plasminogen activator-like protease |
| 04/16/2002 | US6372468 Useful in the development of human therapeutics and diagnostic formulations |
| 04/16/2002 | US6372462 Cultivating a fungi of the basidiomycetes in a submerged culture on nutrient media, isolating the biomass of edible mushrooms from the culture broth, and drying at a range of 40-45 degrees celsius |
| 04/16/2002 | US6372454 Also vectors, host cells; screening methods for identifying agonists or antagonists of follistatin-3 activity; diagnostic methods for detecting reproductive system and cell differentiation disorders and treating these |
| 04/16/2002 | US6372441 Detecting the expression of the variable exon v10 in the cd44 gene in a patient or in a sample obtained from a patient, wherein the expression of the variable exon v10 in the cd44 gene indicates hodgkin's lymphomas |
| 04/16/2002 | US6372431 Mammalian toxicological response markers |
| 04/16/2002 | US6372267 Cocoa solids prepared by heating, pressing, recovering partially defatted cocoa solids which contain cocoa polyphenols including cocoa procyanidins |
| 04/16/2002 | US6372263 Extracted from fertilized ovum of a sea water fish or a fresh water fish |
| 04/16/2002 | US6372262 Serum-derived factor inducing cell differentiation and medical uses thereof |
| 04/16/2002 | US6372250 Non-invasive gene targeting to the brain |
| 04/16/2002 | US6372217 Methods for the treatment of CD7+ viral infection with TXU-7-PAP |
| 04/16/2002 | US6372207 IFNAR2/IFN complex |
| 04/16/2002 | US6372205 Pharmaceutical compositions containing antibody-enzyme conjugates in combination with prodrugs |
| 04/16/2002 | CA2355334A1 Pharmaceutical preparations and methods for inhibiting tumors |
| 04/16/2002 | CA2087414C Arylcycloalkyl derivatives their production and their use |
| 04/16/2002 | CA2046607C Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 04/16/2002 | CA2009690C Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom |
| 04/11/2002 | WO2002029090A1 Subsance inhibiting the binding of signal transducing molecule to kdr/flk-1 phosphorylated at tyrosine at the 1175-position and method of using the same |
| 04/11/2002 | WO2002029088A2 Highly expressible genes |
| 04/11/2002 | WO2002029086A2 Nucleic acid sequences differentially expressed in cancer tissue |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |